No perspectives yet — be the first!
Be the first verified clinician to share a view on Gramicidin.
100% anonymous · NPI-verifiedFDA status last checked Nov 11, 2026
A heterogeneous mixture of six antibiotic peptides obtained from the soil bacterium Bacillus brevis. Gramicidin is active against most Gram-positive bacteria and against select Gram-negative organisms. It is administered as a topical application.
Gramicidin
Approved by the FDA.
We have not yet attached proof for an evidence level.
No brand records are linked yet.
How it works. Proven facts and ideas still being studied are kept apart.
Not yet reviewed.
We have not yet attached proof for an evidence level.
Not yet reviewed.
FDA-approved. Applications: ANDA060427, ANDA060582, ANDA062383, ANDA062788.
Last verified: Nov 11, 2026
Share your perspective on Gramicidin and help peers make informed prescribing decisions.
Your 45-second perspective helps thousands of colleagues.
Your real-world insights guide colleagues
Your identity stays private — only specialty/region shown
Compare your perspective to specialty peers
